Intensity Therapeutics, Inc.

INTSNASDAQHealthcare● Active

$3.82

+$0.04(+1.13%)

Market Cap$7209636

P/E Ratio—

52W High$43.5

52W Low$3.65

Avg Volume29K

Open$3.78

Beta3.06

Cash on Hand Financials Revenue

Intensity Therapeutics, Inc. (INTS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

INTS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$11.9M▲ +360.3% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$11.9M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+360.3%

vs prior fiscal year

Latest Quarter

$10.2M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$11.9MCash on Hand

Total Debt$110,000Total Debt

Net Cash / Net Debt+$11.8MNet Cash Position

Cash vs Debt Ratio

Cash 99%Intensity Therapeutics, Inc. cash as % of market cap: 165.35%% · MCap $0BDebt 1%

Intensity Therapeutics, Inc. has a net cash position of $11.8M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$11.9M − $110,000 = +$11.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

INTS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

INTS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$11.9M+360.3%

Dec 31, 2024FY$2.6M-82.5%

Dec 31, 2023FY$14.8M+1026.2%

Dec 31, 2022FY$1.3M-71.1%

Dec 31, 2021FY$4.5M-51.3%

INTS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

INTS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Intensity Therapeutics, Inc.YOU

INTS

$11.9M$7M165.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Intensity Therapeutics, Inc. (INTS) cash on hand as of December 31, 2025 is $11.9M, comprising $11.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Intensity Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Intensity Therapeutics, Inc. cash reserves or cash position.

Intensity Therapeutics, Inc. annual cash on hand history shows increased +360.3% in 2025: increased +360.3% in 2025. Intensity Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Intensity Therapeutics, Inc. carries total debt of $110,000 against cash of $11.9M, resulting in a net cash position of +$11.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

INTS cash on hand · 5 questions

As of December 31, 2025, Intensity Therapeutics, Inc. (INTS) has $11,921,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $11,921,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $10,245,000. Data sourced from the annual 10-K filing via FMP.

INTS cash on handINTS cash reservesINTS cash 2025how much cash does INTS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Intensity Therapeutics, Inc. · Intensity Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025